Showing results (1-10 of 395) with videos related to
Sort By:
Pageof 40
Journal of Clinical Laboratory Analysis|January 13, 2005
HIV-1 genotype resistance pattern and evolution in patients failing nelfinavir-containing regimensE Quiros-Roldan, F Moretti, C Torti, et al.Infection|June 6, 2003
HIV/HTLV co-infection: frequency and epidemiological characteristics among patients admitted to an Italian hospitalE Quiros-Roldan, F Moretti, C Torti, et al.International Journal of STD & AIDS|February 12, 2005
Risk factors for myocardial infarction in HIV-positive patientsE Quiros-Roldan, C Torti, C Tinelli, et al.Microbios|August 17, 2001
HIV-1 multi-dideoxynucleoside resistance mutation (Q151M): prevalence, associated resistance mutations and response to antiretroviral salvage treatmentE Quiros-Roldan, D Bertelli, S Signorini, et al.Journal of Biological Regulators and Homeostatic Agents|November 24, 1999
HIV-1 pharmacoresistance: clinical and therapeutic implicationsG Carosi, C Torti, L Palvarini, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|September 2, 2000
Mortality for liver disease in patients with HIV infection: a cohort studyM Puoti, A Spinetti, A Ghezzi, et al.Journal of Clinical Laboratory Analysis|February 15, 2001
Analysis of HIV-1 mutation patterns in patients failing antiretroviral therapyE Quiros-Roldan, S Signorini, F Castelli, et al.Journal of Clinical Laboratory Analysis|May 10, 2001
Long-term benefit of genotypic-guided therapy and prevalence of multinucleoside resistance in an Italian group of antiretroviral multiexperienced patientsE Quiros-Roldan, F Moretti, M Airoldi, et al.AIDS Patient Care and Stds|January 7, 2005
Lopinavir plasma levels in salvage regimes by a population of highly active antiretroviral therapy-treated HIV-1-positive patientsC Torti, E Quiros-Roldan, V Tirelli, et al.The New Microbiologica|January 14, 2005
"Solving the puzzle" of current HAART: what key strategic trials are needed?G Carosi, C TortiPageof 40